1. Home
  2. AKRO vs HDL Comparison

AKRO vs HDL Comparison

Compare AKRO & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.65

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

HDL

SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

HOLD

Current Price

$17.35

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKRO
HDL
Founded
2017
2016
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
1.1B
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
AKRO
HDL
Price
$54.65
$17.35
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$73.56
N/A
AVG Volume (30 Days)
2.4M
2.1K
Earning Date
11-07-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
N/A
$820,865,000.00
Revenue This Year
N/A
$11.19
Revenue Next Year
N/A
$13.37
P/E Ratio
N/A
$438.76
Revenue Growth
N/A
8.02
52 Week Low
$21.34
$16.30
52 Week High
$58.40
$30.00

Technical Indicators

Market Signals
Indicator
AKRO
HDL
Relative Strength Index (RSI) 68.63 45.84
Support Level $54.30 $16.70
Resistance Level $54.70 $18.33
Average True Range (ATR) 0.17 0.29
MACD -0.10 -0.01
Stochastic Oscillator 71.07 39.88

Price Performance

Historical Comparison
AKRO
HDL

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

Share on Social Networks: